NOVO.B.DK

453.3

+0.35%↑

GMAB.DK

1,334.5

-1.26%↓

HLUNB.DK

36.34

-0.16%↓

ZEAL.DK

363.9

-1.09%↓

AMBUB.DK

98.7

+2.76%↑

NOVO.B.DK

453.3

+0.35%↑

GMAB.DK

1,334.5

-1.26%↓

HLUNB.DK

36.34

-0.16%↓

ZEAL.DK

363.9

-1.09%↓

AMBUB.DK

98.7

+2.76%↑

NOVO.B.DK

453.3

+0.35%↑

GMAB.DK

1,334.5

-1.26%↓

HLUNB.DK

36.34

-0.16%↓

ZEAL.DK

363.9

-1.09%↓

AMBUB.DK

98.7

+2.76%↑

NOVO.B.DK

453.3

+0.35%↑

GMAB.DK

1,334.5

-1.26%↓

HLUNB.DK

36.34

-0.16%↓

ZEAL.DK

363.9

-1.09%↓

AMBUB.DK

98.7

+2.76%↑

NOVO.B.DK

453.3

+0.35%↑

GMAB.DK

1,334.5

-1.26%↓

HLUNB.DK

36.34

-0.16%↓

ZEAL.DK

363.9

-1.09%↓

AMBUB.DK

98.7

+2.76%↑

Search

Coloplast A-S (Class B)

Затворен

611.2 0.16

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

608

Максимум

619.2

Ключови измерители

By Trading Economics

Приходи

-132M

912M

Продажби

-96M

6.9B

P/E

Средно за сектора

31.242

50.857

EPS

4.34

Дивидентна доходност

3.46

Марж на печалбата

13.16

Служители

16,741

EBITDA

-42M

2.2B

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+11.86% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.46%

2.35%

Следващи печалби

19.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-15B

142B

Предишно отваряне

611.04

Предишно затваряне

611.2

Coloplast A-S (Class B) Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.06.2025 г., 19:24 ч. UTC

Значими двигатели на пазара

Amgen Expands MariTide Development Plans After Weight-Loss Trial -- Update

23.06.2025 г., 19:07 ч. UTC

Значими двигатели на пазара

Amgen Expands MariTide Development Plans After Successful Weight-Loss Trial

23.06.2025 г., 17:29 ч. UTC

Придобивния, сливания и поглъщания

FTC Resolves Antitrust Probe Into Omnicom-Interpublic Merger

23.06.2025 г., 23:44 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

23.06.2025 г., 23:44 ч. UTC

Пазарно говорене

Nikkei May Rise as Fears About Israel-Iran Conflict Ease -- Market Talk

23.06.2025 г., 23:39 ч. UTC

Пазарно говорене

Gold Falls After Trump Says Israel, Iran Agree to Cease-Fire -- Market Talk

23.06.2025 г., 23:39 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

23.06.2025 г., 22:53 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

23.06.2025 г., 21:42 ч. UTC

Печалби

KB Home Cuts FY25 Outlook as 2Q Profit, Sales Fall -- Update

23.06.2025 г., 20:50 ч. UTC

Пазарно говорене
Печалби

Basic Materials Roundup: Market Talk

23.06.2025 г., 20:30 ч. UTC

Пазарно говорене

Canada Employment Data May Be Overstating Job Gains -- Market Talk

23.06.2025 г., 20:24 ч. UTC

Придобивния, сливания и поглъщания

Tesla Stock Surges After Musk's Robo-Taxi Rollout. Where Shares Go From Here. -- Barrons.com

23.06.2025 г., 20:16 ч. UTC

Пазарно говорене

U.S. Stocks Climb After Iran's Retaliation Seen As Measured -- Market Talk

23.06.2025 г., 19:22 ч. UTC

Пазарно говорене

Oil Futures Sink As Iranian Retaliation Seen Weak -- Market Talk

23.06.2025 г., 18:56 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Settle Lower -- Market Talk

23.06.2025 г., 18:49 ч. UTC

Пазарно говорене

Gold Ticks Higher in Cautious Trade -- Market Talk

23.06.2025 г., 18:14 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

23.06.2025 г., 18:14 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Little Changed on Iran's Retaliation -- Market Talk

23.06.2025 г., 17:59 ч. UTC

Пазарно говорене

Oil Futures Fall As Iran Fires Missiles At U.S. Bases in Qatar -- Market Talk

23.06.2025 г., 17:25 ч. UTC

Пазарно говорене

Services Lift Mexico's Economic Activity in April -- Market Talk

23.06.2025 г., 17:22 ч. UTC

Пазарно говорене

Weaker Oil Long-Term Looks to Keep a Lid on Grains -- Market Talk

23.06.2025 г., 17:20 ч. UTC

Пазарно говорене

Mexican Inflation Seen Easing in Early June --Market Talk -- Market Talk

23.06.2025 г., 16:27 ч. UTC

Пазарно говорене
Печалби

Commercial Metals Says Tariffs, Interest Rates Won't Drag on Earnings -- Market Talk

23.06.2025 г., 16:23 ч. UTC

Пазарно говорене
Печалби

Commercial Metals Sees Resilient Demand, Eyes Growth as Economic Uncertainty Eases -- Market Talk

23.06.2025 г., 16:20 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

23.06.2025 г., 16:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

23.06.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

23.06.2025 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

23.06.2025 г., 15:50 ч. UTC

Придобивния, сливания и поглъщания

Credit Agricole Didn't Disclose Financial Details

23.06.2025 г., 15:49 ч. UTC

Придобивния, сливания и поглъщания

Credit Agricole: Impact on Credit Agricole's CET1 Ratio Expected to Be Limited

Сравнение с други в отрасъла

Ценова промяна

Coloplast A-S (Class B) Прогноза

Ценова цел

By TipRanks

11.86% нагоре

12-месечна прогноза

Среден 901.38 DKK  11.86%

Висок 1,056 DKK

Нисък 720 DKK

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Coloplast A-S (Class B) през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

8 ratings

2

Купи

4

Задържане

2

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.